Boss of Open Orphan volunteers for Covid-19 drug trial

Executive chairman of the Irish drug testing firm, Cathal Friel, wants to be part of study which involves being infected by the virus

25th October, 2020
Boss of Open Orphan volunteers for Covid-19 drug trial
Cathal Friel, Open Orphan’s executive chairman, said he had volunteered to be among those involved in the study, although he would not be part of the first group

The head of Open Orphan, the Irish drug trials and testing company, has said he has volunteered to be infected with a dose of Covid-19 as part of a human study into the virus.

Open Orphan’s subsidiary hVIVO won a £40 million (€44 million) contract with the British government last week which will see it conduct what is termed a human challenge trial, that will involve volunteers being given a strain of Covid-19 to study...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Average salary at Google’s Dublin HQ rises to €108,000

Sysnet acquires division of ControlScan

Covid-19 takes huge bite out of Greencore’s British sales

Companies Ian Guider 5 days ago

UDG Healthcare’s Sharp division outperforms its chief executive’s hopes